Lv1
24 积分 2024-03-28 加入
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
22天前
已完结
ESPEN practical guideline: Clinical Nutrition in cancer
22天前
已完结
Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
29天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
29天前
已完结
皖公网安备34019202002308
